HIGH-RESOLUTION CHROMOSOME-BANDING IN SEARCH OF GERM LINE MUTATIONS APPLIED ON TESTICULAR CANCER-PATIENTS

被引:3
|
作者
LOTHE, RA
HEIMDAL, K
LIER, ME
FOSSA, SD
MOLLER, P
BROGGER, A
机构
[1] NORWEGIAN RADIUM HOSP,INST CANC RES,DEPT MED ONCOL,N-0310 OSLO 3,NORWAY
[2] NORWEGIAN RADIUM HOSP,INST CANC RES,DEPT RADIOTHERAPY,N-0310 OSLO 3,NORWAY
关键词
D O I
10.1016/0165-4608(92)90160-A
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Patients with bilateral and/or familial testicular cancer are assumed to demonstrate germ line mutations if such mutations are instrumental in testicular cancer patients. Constitutional rearrangements have to our knowledge not been reported, while an increased level of constitutional chromosome instability has been claimed. Lymphocytes from 12 Norwegian patients with bilateral or familial testicular cancer have been studied by high resolution Giemsa banding. A possible germ line mutation would be expected to be seen in every cell. It is therefore sufficient to examine one pair of the individual chromosomes obtained, if necessary, from several cells. Based on our previous findings of loss of heterozygosity in the chromosome regions 3p and 11p in testicular tumors, these chromosome arms were paid special attention. However, no mutations were observed in these regions nor in any other chromosome. Applying a 95% confidence interval, we conclude that less than 23% of familial and/or bilateral testicular cancer patients are caused by germ line mutations large enough to be detected with high resolution banding of at least 450 G-bands per haploid genome. The presented analyses were used to standarize the resolution determination in our laboratory.
引用
收藏
页码:62 / 67
页数:6
相关论文
共 37 条
  • [31] High Frequency of Heterozygous Truncating Germ-Line Mutations in DNA Repair Genes in Young-Onset and/or ALK-Rearranged Lung Cancer Patients
    Imyanitov, E.
    Sokolenko, A.
    Iyevleva, A.
    Tiurin, V.
    Sokolova, T.
    Ivantsov, A.
    Mitiushkina, N.
    Orlov, S.
    Levchenko, E.
    Bizin, I.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S534 - S534
  • [32] GERM-LINE MUTATIONS OF THE P53 TUMOR SUPPRESSOR GENE IN PATIENTS WITH HIGH-RISK FOR CANCER INACTIVATE THE P53 PROTEIN
    FREBOURG, T
    KASSEL, J
    LAM, KT
    GRYKA, MA
    BARBIER, N
    ANDERSEN, TI
    BORRESEN, AL
    FRIEND, SH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (14) : 6413 - 6417
  • [33] Detection of PIK3CA somatic mutations in cell-free DNA of breast cancer patients by high-resolution melting curve analysis
    Schiza, Christina
    Farkona, Sofia
    Chimonidou, Maria
    Vorkas, Panos
    Malamos, Nikos
    Georgoulias, Vasilis
    Lianidou, Evi S.
    CANCER RESEARCH, 2012, 72
  • [34] EGFR mutations detected by high-resolution melting analysis (HRMA) as a predictor of response and survival in non-small cell lung cancer (NSCLC) patients treated with gefitinib.
    Takano, T.
    Ohe, Y.
    Furuta, K.
    Tsuta, K.
    Nomoto, K.
    Matsuno, Y.
    Fukui, T.
    Sekine, I.
    Kunitoh, H.
    Tamura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 382S - 382S
  • [35] Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis
    Smith, G. D.
    Chadwick, B. E.
    Willmore-Payne, C.
    Bentz, J. S.
    JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (04) : 487 - 493
  • [36] Screening of CHEK2 and TP53 p.R337H germ-line mutations in high-risk patients for hereditary breast and ovarian cancer from northeast of Brazil.
    Oliveira Nascimento, Ivana Lucia
    Santo Felix, Gabriela Espirito
    Bonfim Machado-Lopes, Taisa Manuela
    Bomfim, Thais
    Romeo, Maura
    Toralles, Betania
    Garicochea, Bernardo
    Meyer, Roberto
    Abe-Sandes, Kiyoko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer:: An extended phase I/II study of the German testicular cancer study group
    Schmoll, HJ
    Kollmannsberger, C
    Metzner, B
    Hartmann, JT
    Schleucher, N
    Schöffski, P
    Schleicher, J
    Rick, O
    Beyer, J
    Hossfeld, D
    Kanz, L
    Berdel, WE
    Andreesen, R
    Bokemeyer, C
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) : 4083 - 4091